Hai Fang, PhD in Economics

Professor, Doctoral Advisor, China Center for Health Development Studies, Peking University

Vice Director, Peking University Health Science Center and China CDC Joint Research Center for Vaccine Economics

 

Hai Fang, PhD in Economics, Professor and Doctoral Advisor in China Center for Health Development Studies, Peking University. Vice Director of Peking University Health Science Center and China CDC Joint Research Center for Vaccine Economics; Director of Vaccine Economic Committee in China Association for Vaccine; Vice Director and Secretary General of Public Health Economic Committee in China Health Economic Association. Before joining Peking University, Professor Fang taught at the University of California Davis, the University of Miami in Florida, and the University of Colorado Denver in the United States as faculty (Lecturer, Assistant Professor, and Associate Professor). Professor Fang has been the principal investigator (PI) for research projects funded by National Social Science Fund of China (Chief Expert for Major Project), National Natural Science Foundation of China, Beijing Natural Science Foundation, China CDC, National Bureau of Disease Control and Prevention, Chinese Preventive Medicine Association, Chinese Medical Doctor Association, UNICEF, Bill & Melinda Gates Foundation, China Medical Board (CMB) in the United States, and Medical Research Council (MRC) in the United Kingdom. Professor Fang is the principle editor for China Guidelines for Vaccine Economic Evaluation 2022 and has published more than 150 Chinse and English research articles, including BMJ, Lancet Public Health as the first or corresponding author.

 

2003 - 2006   PhD in Economics, State University of New York at Stony Brook, USA

2004 - 2006   MPH, State University of New York at Stony Brook, USA

2001 - 2003   MA in Economics, State University of New York at Stony Brook, USA

1998 - 2001   MA in Economics, Nankai University, China

1993 - 1997   BA in Economics, Tianjin University of Finance and Economics, China

 

2012 - present Professor, Doctoral Advisor

                                China Center for Health Development Studies

2019 - present Vice Director

2009 - 2013 Assistant Professor/Associate Professor 

                                University of Colorado Denver, USA

2007 - 2009 Research Assistant Professor

2007 - 2009             Research Associate (Affiliated)

2006 - 2007             Lecturer

 

2022 - present    Director, Vaccine Economic Committee, China Association for Vaccine

2019 - present Vice Director and Secretary General, Public Health Economic Committee, China Health Economic Association

 

2021 – 2024 Public health management system study, National Social Science Fund of China (Major Project 重大专项), Principal Investigator (Chief Expert)

2022 – 2024 Real-world effectiveness, safety, and health economic evaluation of varicella vaccine, Beijing Natural Science Foundation (Key Project 重点项目), Principal Investigator

2021 – 2024 Health economic evaluation of Covid-19 vaccination, National Key Research and Development Program of China, Principal Investigator of a Task

2022 – 2024 The function and mechanism of primary care on chronic disease management: a health system perspective, Beijing Natural Science Foundation, Principal Investigator 

2019 – 2020  The 1st National Natural Science Foundation of China and Bill & Melinda Gates Foundation Global Health Joint Symposium, Bill & Melinda Gates Foundation/National Natural Science Foundation of China, Principal Investigator

2019 – 2020 An Economic Evaluation of Haemophius Influenzae Type b (Hib) Vaccine for the introduction of China’s National Immunization Program (NIP), Bill and Melinda Gates Foundation, Principal Investigator

2018 – 2021  Family physician contract services and impacts in China based on physician agency theory, National Natural Science Foundation of China, Principal Investigator

2018 – 2019 A subsidy program of gestational diabetes mellitus screening and lifestyle treatment in rural China, China Medical Board (CMB) in the United States, Principal Investigator

2015 – 2018 Learning from health systems strengthening in maternal and newborn health (MNH) in China to inform accelerated progress for saving，Medical Research Council/London School of Hygiene and Topical Medicine in the United Kingdom, Principal Investigator

2014 – 2017 The effects of China’s medical security system on health inequality in the context of medical reform, National Natural Science Foundation of China, Principal Investigator

 

(# Corresponding author or co-corresponding author (senior author); * Supervised graduate students or post-doctors as the first or co-first author)

1. Fang H#, Eggleston K, Hanson K, Wu M. Enhancing financial protection under China’s social health insurance to achieve universal health coverage. BMJ 2019;365:l2378. 

2. Zhang H*, Lai X*, Patenaude BN, Jit M, Fang H#, Adding new childhood vaccines to China’s National Immunization Program: evidence, benefits, and priorities. Lancet Public Health 2023;8(12):e1016-e1024.

3. Lai X*, Zhang H*, Pouwels KB, Patenaude B, Jit M, Fang H#. Estimating global and regional between-country inequality in routine childhood vaccine coverage in 195 countries and territories from 2019 to 2021: a longitudinal study. EClinicalMedicine 2023;60:102042. 

4. Lai X*, Yuan Y, Wang H, Zhang R, Qiao Q, Feng X, Jin A, Li H, Li J, Si L, Gao P, Jan S, Fang H#, Wu Y#; DECIDE-Salt Research Group. Cost-Effectiveness of Salt Substitute and Salt Supply Restriction in Eldercare Facilities: The DECIDE-Salt Cluster Randomized Clinical Trial. JAMA Network Open. 2024 Feb 5;7(2):e2355564. 

5. Zhang H*, Patenaude B, Zhang H, Jit M, Fang H#. Global vaccine coverage and childhood survival estimates 1990-2019. Bulletin of World Health Organization 2024; BLT.23.290129. https://cdn.who.int/media/docs/default-source/bulletin/online-first/blt.23.290129.pdf?sfvrsn=8c6c239c_3

6. Feng H*, Zhang H, Ma C, Zhang H, Yin D#, Fang H#. National and provincial burden of varicella disease and cost-effectiveness of childhood varicella vaccination in China from 2019 to 2049: a modelling analysis. Lancet Regional Health Western Pacific. 2023 March;32:100639. (IF=8.559) 

7. Lai X*, Garcia C, Wu D, Knoll M, Zhang H, Xu T, Jing R, Ying Z#, Wahl B#, Fang H#. Estimating national, regional and provincial cost-effectiveness of introducing childhood 13-valent pneumococcal conjugate vaccination in China: a modelling analysis. Lancet Regional Health Western Pacific. 2023 March;32:100666. (IF=8.559) 

8. Zhang H*, Lai X, Mak J, Sriudomporn S, Zhang H, Fang H#, Patenaude B. Coverage and Equity of Childhood Vaccines in China. JAMA Network Open. 2022;5(12):e2246005. (IF=13.353)

9. Zhang H*, Garcia C, Yu W, Knoll M, Lai X, Xu Ting, Jing R, Qin Y, Yin Z#, Wahl B#, Fang H#. National and provincial impact and cost3 effectiveness of Haemophilus influenzae type b conjugate vaccine in China: a modeling analysis. BMC Medicine. 2021 Aug 11;19(1):181. (IF=8.775) 

10. Rong H*, Lai X, Jing R, Wang X, Fang H#, Mahmoudi E. Association of sensory impairments with cognitive decline and depression among older adults in China. JAMA Network Open. 2020;3(9):e2014186. (IF=8.485)

 

Fang H, Editor, China Guidelines for Vaccine Economic Evaluation 2022, Peking University Health Science Center – China CDC Joint Research Center for Vaccine Economics 

Fang H, Editor, Economic Evaluation of Five Non-Expanded Program on Immunization Vaccines in China, People’s Medical Publishing House, 2021

Fang H, Rizzo JA. Physician labor supply, in Encyclopedia of Health Economics, edited by Culyer A. Elsevier. 2014, pp.56-60.

 

2021 - 2022 Best head teacher, Peking University

2020 - 2021 Excellent teaching award, Peking University Health Science Center